Search Results

You searched for : Immixbio

	ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma Latest pharma news update... Oct 04
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
2 Matching result(s) found!

-Advertisements-

Trending Now
	Pervez Musharraf President of Pakistan died of Amyloidosis, a rare diseaseFebruary 07, 2023
	National AIDS Control Program – Importance of knowing HIV statusFebruary 06, 2023
	FGM : Let's End the practice that hurts girls and womenFebruary 06, 2023
	World Cancer Day - Most prominent cancers of IndiaFebruary 04, 2023
	World Cancer Day - Never Give up the HopeFebruary 04, 2023
	Salt - Effects of Consuming too much SaltFebruary 03, 2023
	India’s mission of eliminating dog-mediated rabies by 2030February 03, 2023
	Climate change and healthFebruary 02, 2023
	Rheumatoid Arthritis Awareness Day: Let's Create AwarenessFebruary 02, 2023
	Importance of early diagnosis and cancer screeningFebruary 01, 2023
	Union Budget 2023-2024: What's for Healthcare?February 01, 2023
	Nourish You has raised $2million to Invest in R&D and Strengthen its Market Presence.February 01, 2023
	Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
	Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
	World Leprosy Day 2023 – Act now, End LeprosyJanuary 30, 2023
	The Warrior Expedition 32/26: A Mission to Encourage Youths to join Indian ForcesJanuary 30, 2023
	Mental health – What’s normal and what’s abnormalJanuary 30, 2023
	Big Data in Healthcare and Its BenefitsJanuary 27, 2023
	Patient Advocacy - The voice of patientJanuary 27, 2023
	Republic Day - Vision of Healthy IndiaJanuary 25, 2023